Cognitive Functioning and Cortical Brain Thickness in Acromegaly Patients: A Pilot study.

CONCLUSIONS: In conclusion, in this pilot study, the type of pharmacological treatment in patients with acromegaly and good glycemic control did not influence the cognitive function and cortical brain thickness. However, pegvisomant could play a neuroprotective role on the thalamus that will have to be demonstrated with larger samples in future studies. PMID: 33200172 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33200172?dopt=Abstract

Source: Archives of Clinical Neuropsychology - November 17, 2020 Category: Psychiatry & Psychology Authors: García-Casares N, Fernández-Andújar M, González-Molero I, Maraver-Selfa S, Gutiérrez-Bedmar M, Ramos-Rodriguez JR, Alfaro-Rubio F, Roé-Vellvé N, Garcia-Garcia I, García-Arnés JA Tags: Arch Clin Neuropsychol Source Type: research